Brief: Yichang Hec Changjiang Pharmaceutical Expects Q4 Revenue Of RMB1,780 Mln, Up 125%
Jan 2 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* EXPECTS THAT CO WILL RECORD A REVENUE OF ABOUT RMB1,780
MILLION
FOR 3 MONTHS FROM 1 OCT 2019 TO 31 DEC 2019
* EXPECTED INCREASE IN REVENUE DUE TO CONTINUOUS INCREASE IN
SALES
REVENUE OF CO'S PRODUCT KEWEI
Source text for Eikon: urn:newsml:reuters.com:*:nHKS4PtJcC
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million